Atomnaut, with its slogan "Think small to think big," is on a mission to transform the materials engineering landscape. The company aims to revolutionize the industry by providing a 'Human Genome Project' for materials, including silicon, steel, tungsten, and more.
The conventional materials engineering process is plagued by slow development timelines and exorbitant costs, with new materials taking up to 20 years to develop and semiconductor R&D costing $64 billion in 2014. The primary challenge lies in the absence of comprehensive data that elucidates how atoms influence material properties, leading to a reliance on costly trial-and-error experiments.
Addressing this fundamental issue, Atomnaut has introduced groundbreaking imaging technology that enables the mapping of every atom's 3D position and element identity – a tremendous 100x improvement. This data serves as the material's 'blueprint' or 'DNA,' facilitating the replacement of experiments with computational modeling to design patentable materials and manufacturing processes.
Founded in 2015, Atomnaut has emerged as a key player in the Design, Manufacturing, and 3D Printing sectors. The company's innovative approach has garnered investment from BioTools Innovator, with the latest non-equity assistance investment occurring on 06 June 2023.
Atomnaut's offerings include materials characterization services, data analytics for the design of patentable materials and manufacturing processes, as well as access to a library of 3D atomic structures through the Encyclopedia Atomica.
With its pioneering technology and disruptive vision, Atomnaut is poised to catalyze a paradigm shift in materials engineering, promising significant returns for investors and groundbreaking advancements in various industries.
For more information, visit Atomnaut.
